An Achilles' Heel for MLL-Rearranged Leukemias: Writers and Readers of H3 Lysine 36 Dimethylation

Balbach ST, Orkin SH

Research article (journal) | Peer reviewed

Abstract

Histone H3 lysine 36 dimethylation (H3K36me2), a modification associated with transcriptional activation, is required for mixed-lineage leukemia-dependent transcription and leukemic transformation. In this issue of Cancer Discovery, Zhu and colleagues map the network of readers, writers, and erasers of H3K36me2 and uncover the ASH1L histone methyltransferase as a novel target for therapeutic intervention. Cancer Discov; 6(7); 700-2. {çopyright}2016 AACR.See related article by Zhu and colleagues, p. 770.

Details about the publication

Volume6
Issue7
Page range700-702
StatusPublished
Release year2016
Language in which the publication is writtenEnglish
DOI10.1158/2159-8290.CD-16-0564

Authors from the University of Münster

Balbach, Sebastian
University Children's Hospital - Department of Paediatric Haematology and Oncology (UKM PHO)